UC-Care We believe better health outcomes can only be realized when technological advancements are successfully integrated within current systems and workflows. Thus, innovation at UC-CARE is sparked by a deep understanding of health practitioner realities. Our solutions are designed consciously, with technological, workflow and business realities held central, in order to meet the needs of, and be easily integrated by, physicians, technicians and patients. Today UC-CARE’s focus is the development of unique, patented tools that turn blind diagnostics into smart diagnostics that enable focal treatment procedures of prostate diseases. PRECISION IN THE PRESENCE OF MOVEMENT. End-to-end solutions for prostate cancer diagnosis and treatment that automatically adapt to physician, patient and technician clinical realities. Diagnostic and treatment precision in fusion technology can only be achieved when human movement at every point-of-care is accounted for. SmartBx PATHOLOGY PRECISION, REIMAGINED. By maintaining core location and orientation while preserving specimen integrity from needle to slide, the SmartBx biopsy management system has proven to increase detection rates by 25%.
Looking for a particular UC-CARE employee's phone or email?
The UC-CARE annual revenue was $4 million in 2026.
Tomer Schatzberger is the CEO of UC-CARE.
14 people are employed at UC-CARE.
The NAICS codes for UC-CARE are [334, 33].
The SIC codes for UC-CARE are [38, 384].